3//SEC Filing
New Leaf Venture Management III, L.L.C. 3
Accession 0001104659-18-041349
CIK 0001674365other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 7:42 PM ET
Size
18.2 KB
Accession
0001104659-18-041349
Insider Transaction Report
Form 3
Aptinyx Inc.APTX
Holdings
- (indirect: See footnotes)
Series B Convertible Preferred Stock
→ Common Stock (552,208 underlying) - (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (243,345 underlying) - (indirect: See footnotes)
Series A-1 Convertible Preferred Stock
→ Common Stock (1,047,450 underlying) - (indirect: See footnotes)
Series A-2 Convertible Preferred Stock
→ Common Stock (1,197,076 underlying)
Holdings
- (indirect: See footnotes)
Series A-1 Convertible Preferred Stock
→ Common Stock (1,047,450 underlying) - (indirect: See footnotes)
Series A-2 Convertible Preferred Stock
→ Common Stock (1,197,076 underlying) - (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (243,345 underlying) - (indirect: See footnotes)
Series B Convertible Preferred Stock
→ Common Stock (552,208 underlying)
New Leaf Ventures III, L.P.
10% Owner
Holdings
- (indirect: See footnotes)
Series A-2 Convertible Preferred Stock
→ Common Stock (1,197,076 underlying) - (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (243,345 underlying) - (indirect: See footnotes)
Series B Convertible Preferred Stock
→ Common Stock (552,208 underlying) - (indirect: See footnotes)
Series A-1 Convertible Preferred Stock
→ Common Stock (1,047,450 underlying)
Holdings
- (indirect: See footnotes)
Series B Convertible Preferred Stock
→ Common Stock (552,208 underlying) - (indirect: See footnotes)
Series A-1 Convertible Preferred Stock
→ Common Stock (1,047,450 underlying) - (indirect: See footnotes)
Series A-2 Convertible Preferred Stock
→ Common Stock (1,197,076 underlying) - (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (243,345 underlying)
New Leaf BPO Associates I, L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (243,345 underlying) - (indirect: See footnotes)
Series B Convertible Preferred Stock
→ Common Stock (552,208 underlying) - (indirect: See footnotes)
Series A-1 Convertible Preferred Stock
→ Common Stock (1,047,450 underlying) - (indirect: See footnotes)
Series A-2 Convertible Preferred Stock
→ Common Stock (1,197,076 underlying)
Footnotes (4)
- [F1]All series of convertible preferred stock will automatically convert into the number of shares of the Issuer's common stock on a 27.58621-for-1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
- [F2]These shares are held directly by New Leaf Ventures III, L.P. ("NLV-III"). The general partner of NLV-III is New Leaf Venture Associates III, L.P. ("NLVA-III"). The general partner of NLVA-III is New Leaf Venture Management III, L.L.C. ("Management-III"). Each of NLVA-III and Management-III disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLVA-III or Management-III are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein. Ronald M. Hunt, Vijay K. Lathi, and Liam T. Ratcliffe, a member of the Issuer's board of directors, are the managers of Management-III (each, a "Manager" and collectively, the "Managers") and may each be deemed to have shared voting and investment power with respect to these securities.
- [F3]Each of the Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F4]These shares are held directly by New Leaf Ventures Biopharma Opportunities I, L.P. ("NLV Biopharma"). The general partner of NLV Biopharma is New Leaf BPO Associates I, L.P. ("NLBA-I"). The general partner of NLBA-I is Management-III. Each of NLVB-I and Management-III disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLVB-I or Management-III are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein. The Managers may be deemed to have shared voting and investment power with respect to these securities. Each of the Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Documents
Issuer
Aptinyx Inc.
CIK 0001674365
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001625657
Filing Metadata
- Form type
- 3
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 7:42 PM ET
- Size
- 18.2 KB